2 false false false false false false false false true false true false false false false false false No description of principal activity 2023-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 13334928 2023-04-01 2024-03-31 13334928 2024-03-31 13334928 2023-03-31 13334928 2022-04-01 2023-03-31 13334928 2023-03-31 13334928 2022-03-31 13334928 bus:LeadAgentIfApplicable 2023-04-01 2024-03-31 13334928 bus:Director1 2023-04-01 2024-03-31 13334928 core:WithinOneYear 2024-03-31 13334928 core:WithinOneYear 2023-03-31 13334928 core:ShareCapital 2024-03-31 13334928 core:ShareCapital 2023-03-31 13334928 core:RetainedEarningsAccumulatedLosses 2024-03-31 13334928 core:RetainedEarningsAccumulatedLosses 2023-03-31 13334928 bus:SmallEntities 2023-04-01 2024-03-31 13334928 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 13334928 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 13334928 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 13334928 bus:AbridgedAccounts 2023-04-01 2024-03-31 13334928 core:ComputerEquipment 2023-04-01 2024-03-31
STATEMENT OF CONSENT TO PREPARE ABRIDGED FINANCIAL STATEMENTS
All of the members of Chaudhry Medicare Limited have consented to the preparation of the abridged statement of income and retained earnings and the abridged statement of financial position for the year ending 31 March 2024 in accordance with Section 444(2A) of the Companies Act 2006.
COMPANY REGISTRATION NUMBER: 13334928
CHAUDHRY MEDICARE LIMITED
FILLETED UNAUDITED ABRIDGED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 March 2024
CHAUDHRY MEDICARE LIMITED
REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY ABRIDGED FINANCIAL STATEMENTS OF CHAUDHRY MEDICARE LIMITED
YEAR ENDED 31 MARCH 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the abridged financial statements of Chaudhry Medicare Limited for the year ended 31 March 2024, which comprise the abridged statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at www.accaglobal.com/en/member/professional-standards/rules-standards/acca-rulebook.html. Our work has been undertaken in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/technical-factsheet-163.pdf.
LANGARD LIFFORD HALL LIMITED Accountants and Registered Auditors
Lifford Hall Lifford Lane Kings Norton Birmingham B30 3JN
4 April 2024
CHAUDHRY MEDICARE LIMITED
ABRIDGED STATEMENT OF FINANCIAL POSITION
31 March 2024
2024
2023
Note
£
£
£
£
Fixed assets
Tangible assets
5
1,897
2,685
Current assets
Debtors
6,192
5,673
Cash at bank and in hand
60,975
40,821
------------
------------
67,167
46,494
Creditors: amounts falling due within one year
42,783
22,675
------------
------------
Net current assets
24,384
23,819
------------
------------
Total assets less current liabilities
26,281
26,504
------------
------------
Net assets
26,281
26,504
------------
------------
Capital and reserves
Called up share capital
100
100
Profit and loss account
26,181
26,404
------------
------------
Shareholders funds
26,281
26,504
------------
------------
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
CHAUDHRY MEDICARE LIMITED
ABRIDGED STATEMENT OF FINANCIAL POSITION (continued)
31 March 2024
These abridged financial statements were approved by the board of directors and authorised for issue on 4 April 2024 , and are signed on behalf of the board by:
I Haq
Director
Company registration number: 13334928
CHAUDHRY MEDICARE LIMITED
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
YEAR ENDED 31 MARCH 2024
1. General Information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lifford Hall Lifford Lane, Kings Norton, Birmingham, West Midlands, B303JN, United Kingdom.
2. Statement of Compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting Policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
33% straight line
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
4. Employee Numbers
The average number of persons employed by the company during the year amounted to 2 (2023: 2 ).
5. Tangible Assets
£
Cost
At 1 April 2023 and 31 March 2024
2,685
------------
Depreciation
At 1 April 2023
Charge for the year
788
------------
At 31 March 2024
788
------------
Carrying amount
At 31 March 2024
1,897
------------
At 31 March 2023
2,685
------------
6. Related Party Transactions
At the balance sheet date the company owed £33,595 to Haq Medicare Limited and The Chaudhry Shabbir Ahmed Trust, a company and a Trust with common directors. Administration costs of £25,000 were charged from Haq Medicare Limited during the period.